Quanterix (QTRX) FCF Margin Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | -1,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,492.00 |
| Dec 31, 2025 | -6,530.00 |
| Sep 30, 2025 | -2,868.00 |
| Jun 30, 2025 | 2,890.00 |
| Mar 31, 2025 | 2,821.00 |
| Dec 31, 2024 | -1,657.00 |
| Sep 30, 2024 | 5,121.00 |
| Jun 30, 2024 | 4,799.00 |
| Mar 31, 2024 | -1,239.00 |
| Dec 31, 2023 | -3,594.00 |
| Sep 30, 2023 | 1,119.00 |
| Jun 30, 2023 | 6,686.00 |
| Mar 31, 2023 | 4,941.00 |
| Dec 31, 2022 | 5,161.00 |
| Sep 30, 2022 | -7,574.00 |
| Jun 30, 2022 | 2,890.00 |
| Mar 31, 2022 | 1,321.00 |
| Dec 31, 2021 | 6,548.00 |
| Sep 30, 2021 | 1,207.00 |
| Jun 30, 2021 | -2,666.00 |
| Mar 31, 2021 | 8,766.00 |
| Dec 31, 2020 | 7,609.00 |
| Sep 30, 2020 | 11,236.00 |
| Jun 30, 2020 | 6,455.00 |
| Mar 31, 2020 | -818.00 |